Phase I trial of obatoclax mesylate in combination with bortezomib for treatment of relapsed multiple myeloma.
A. Keith Stewart
Consultant or Advisory Role - Celgene
Honoraria - Millennium
Research Funding - Millennium
Suzanne Trudel
No relevant relationships to disclose
Jeffrey A. Zonder
Research Funding - Celgene; Millennium
Suzanne R. Hayman
No relevant relationships to disclose
Charles Erlichman
No relevant relationships to disclose
Briant Fruth
No relevant relationships to disclose
Betsy LaPlant
No relevant relationships to disclose
Daniel Sullivan
No relevant relationships to disclose